68 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PACB Pacific Biosciences of California, Inc. $5.14 $678.18M Downtrend
Article Searches
Here's Why Pacific Biosciences of California Is Surging Today https://www.fool.com/investing/2018/01/25/heres-why-pacific-biosciences-of-california-is-sur.aspx?source=iedfolrf0000001 Jan 25, 2018 - Another big purchase order for the genome sequencing equipment manufacturer ahead of its full-year 2017 earnings report is just what investors wanted to see.
What's in Store for Pacific Biosciences (PACB) in Q4 Earnings? http://www.zacks.com/stock/news/289856/whats-in-store-for-pacific-biosciences-pacb-in-q4-earnings?cid=CS-ZC-FT-289856 Jan 24, 2018 - Pacific Biosciences (PACB) is likely to witness year-over-year decline in product revenues.
Pacific Biosciences of California (PACB) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow https://seekingalpha.com/article/4136696-pacific-biosciences-california-pacb-presents-36th-annual-j-p-morgan-healthcare-conference?source=feed_sector_healthcare Jan 10, 2018 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Pacific Biosciences Hurt by Competition in Niche Markets http://www.zacks.com/stock/news/288400/pacific-biosciences-hurt-by-competition-in-niche-markets?cid=CS-ZC-FT-288400 Jan 10, 2018 - Pacific Biosciences (PACB) faces cutthroat competition in the niche space. Also, sluggishness in the European markets is a concern.
PacBio's Library Preparation Issues Announced At A Tough Time https://seekingalpha.com/article/4136402-pacbios-library-preparation-issues-announced-tough-time?source=feed_tag_editors_picks Jan 09, 2018 - Recent publication calls into question the library preparation method commonly used for sequencing. Correcting this issue may cause short term stress and will test the company's ability to respond to
Your Daily Pharma Scoop: Axovant's Promised Upside, Gilead's Whistleblower Trouble, PTCT Adcomm Negative https://seekingalpha.com/article/4110589-daily-pharma-scoop-axovants-promised-upside-gileads-whistleblower-trouble-ptct-adcomm?source=feed_sector_healthcare Sep 29, 2017 - Axovant is being pushed again.Gilead faces whistleblower lawsuit similar to Celgene’s.As we expected, PTCT’s Ad comm voted 10-1 against approval in present form.
Pacific Biosciences of California (PACB) Presents At Photonics Summit and Workshop - Slideshow https://seekingalpha.com/article/4104472-pacific-biosciences-california-pacb-presents-photonics-summit-workshop-slideshow?source=feed_all_articles Sep 06, 2017 - The following slide deck was published by Pacific Biosciences of California in conjunction with this event.
Pacific Biosciences Is Advancing Genomics https://seekingalpha.com/article/4100251-pacific-biosciences-advancing-genomics?source=feed_sector_healthcare Aug 18, 2017 - The age of gene therapy approval by the FDA is upon us as investors, signaling near-term rising investor sentiment in the sector.Pacific Biosciences SMRT technology is an industry-leading genomics pla
What's Behind Pacific Biosciences of California's Stock Rally Today? https://www.fool.com/investing/2017/08/07/whats-behind-pacific-biosciences-of-californias-st.aspx?source=iedfolrf0000001 Aug 07, 2017 - Shares of the high-accuracy genomic sequencing company continue to rise despite a lack of significant news.
Week 32 Breakout Forecast: Short-Term Picks To Give You An Edge https://seekingalpha.com/article/4095365-week-32-breakout-forecast-short-term-picks-give-edge?source=feed_all_articles Aug 05, 2017 - 8 new breakout stocks for Week 32 with better than 10% short-term upside potential.4 new breakdown stocks for Week 32 with substantial downside potential.Last week several good momentum selection stre

Pages: 1234567

<<<Page 4>